During the past decade, National Hospital Organization Niigata National Hospital conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 9 clinical trials were completed, i.e. on average, 128.6% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 6 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "National Hospital Organization Niigata National Hospital" #1 sponsor was "Janssen Research & Development, LLC" with 3 trials, followed by "Pfizer" with 3 trials sponsored, "Shire" with 2 trials sponsored, "Hoffmann-La Roche" with 1 trials sponsored and "Taiho Pharmaceutical Co., Ltd." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "National Hospital Organization Niigata National Hospital" #1 collaborator was "Takeda Development Center Americas, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "National Hospital Organization Niigata National Hospital" are "Alzheimer Disease" (3 trials), "Nervous System Diseases" (2 trials), "Duchenne Muscular Dystrophy" (1 trials), "Huntingtons Disease" (1 trials) and "Respiratory Syncytial Virus Infections" (1 trials). Many other conditions were trialed in "National Hospital Organization Niigata National Hospital" in a lesser frequency.

Most popular intervention types in "National Hospital Organization Niigata National Hospital" are "Drug" (10 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Lumicitabine" (2 trials), "SHP615" (2 trials), "bapineuzumab" (2 trials) and "placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "National Hospital Organization Niigata National Hospital" are 9 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "National Hospital Organization Niigata National Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in National Hospital Organization Niigata National Hospital, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in National Hospital Organization Niigata National Hospital, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".